Cardiac output increases by 50% during pregnancy due to a rise in blood volume, decreased vascular resistance, and increased heart rate. Pulmonary changes include hyperventilation, upward displacement of the diaphragm reducing lung capacity by 20%, and increased oxygen consumption. Perimortem cesarean section improves maternal resuscitation by removing aortocaval compression and allowing blood to reperfuse the systemic circulation.
Ovarian Hyperstimulation Syndrome(OHSS), is a Rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy where a patient's ovaries become swollen and fluid builds up around her abdomen
Ovarian Hyperstimulation Syndrome(OHSS), is a Rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy where a patient's ovaries become swollen and fluid builds up around her abdomen
Maternal collapse by dr alka mukherjee &; dr apurva mukherjeealka mukherjee
Not all maternal deaths are preceded by an identifiable collapse, and not all maternal collapses result in death. Maternal collapse occurs any time during pregnancy, up to 42 days following delivery and is an acute event involving cardiorespiratory systems and/or brain, resulting in impaired consciousness or death.1
Maternal deaths are generally quantified as a maternal mortality ratio (MMR), expressed as the number of maternal deaths per 100,000 women giving birth. It includes deaths that occur due to complications of the pregnancy (direct deaths), and those resulting from worsening of other disease processes due to the pregnancy (indirect deaths). Deaths that occur from causes completely unrelated to pregnancy or birth are termed When faced with an acute maternal collapse, it is helpful to think of potential causes as falling into five categories, or the 5 Hs for simplicity:4
Head including eclampsia, stroke, epilepsy, vasovagal
Heart including myocardial infarction, arrhythmia, cardiomyopathy, thoracic aortic dissection
Hypoxia including pulmonary embolus, pulmonary oedema, anaphylaxis, asthma
Haemorrhage including abruption, uterine atony, genital tract trauma, uterine rupture, uterine inversion, ruptured aortic aneurysm
wHole body and Hazards amniotic fluid embolus, hypoglycaemia, trauma, anaesthetic complications, drug reactions (illicit or prescribed), sepsis
The likelihood of any one of these being causative will obviously depend somewhat on the timing of the collapse – early or late pregnancy, intrapartum, immediately postpartum, remotely postpartum.
Maternal cardiac arrest represents a small subset of women affected by maternal collapse. The incidence is approximately 1 in 30,000 ongoing pregnancies, with a high likelihood of death for both the mother and the fetus. The vast majority of us will never need to attend a maternal cardiac arrest, and doing so is uniquely stressful. For these reasons, it is important to have a framework in mind of how to deal with a maternal cardiac arrest, and to have practised the response to this situation.
incidental deaths, and are not included in calculation of the MMR.
• Several other risk factors for maternal death are recognised. These include:
• Maternal age 35 and older
• Obesity
• Lower socioeconomic status
• Pre-existing mental health issues, substance use and domestic violence, all of which may be exacerbated by pregnancy and the puerperium
• Medical co-morbidities, particularly asthma, autoimmune diseases, inflammatory and atopic disorders, haematological disorders, essential hypertension, infections and musculoskeletal disorders
One of the important developments in improving identification of a pregnant or postnatal patient at risk of collapse during hospital admission has been the development of maternity-specific Early Warning Charts.
For difficult vaginal delivery,forceps delivery,vacuum application are done to assist the vaginal delivery.Many types of forceps are there divided in 3 categories.
Approach to maternal collapse and cardiac arrest.pptxKTD Priyadarshani
This is a case based discussion on approach to maternal collapse and cardiac arrest. It includes a detailed account on ERC ALS guideline on maternal cardiac arrest and post resuscitation care.
Maternal collapse by dr alka mukherjee &; dr apurva mukherjeealka mukherjee
Not all maternal deaths are preceded by an identifiable collapse, and not all maternal collapses result in death. Maternal collapse occurs any time during pregnancy, up to 42 days following delivery and is an acute event involving cardiorespiratory systems and/or brain, resulting in impaired consciousness or death.1
Maternal deaths are generally quantified as a maternal mortality ratio (MMR), expressed as the number of maternal deaths per 100,000 women giving birth. It includes deaths that occur due to complications of the pregnancy (direct deaths), and those resulting from worsening of other disease processes due to the pregnancy (indirect deaths). Deaths that occur from causes completely unrelated to pregnancy or birth are termed When faced with an acute maternal collapse, it is helpful to think of potential causes as falling into five categories, or the 5 Hs for simplicity:4
Head including eclampsia, stroke, epilepsy, vasovagal
Heart including myocardial infarction, arrhythmia, cardiomyopathy, thoracic aortic dissection
Hypoxia including pulmonary embolus, pulmonary oedema, anaphylaxis, asthma
Haemorrhage including abruption, uterine atony, genital tract trauma, uterine rupture, uterine inversion, ruptured aortic aneurysm
wHole body and Hazards amniotic fluid embolus, hypoglycaemia, trauma, anaesthetic complications, drug reactions (illicit or prescribed), sepsis
The likelihood of any one of these being causative will obviously depend somewhat on the timing of the collapse – early or late pregnancy, intrapartum, immediately postpartum, remotely postpartum.
Maternal cardiac arrest represents a small subset of women affected by maternal collapse. The incidence is approximately 1 in 30,000 ongoing pregnancies, with a high likelihood of death for both the mother and the fetus. The vast majority of us will never need to attend a maternal cardiac arrest, and doing so is uniquely stressful. For these reasons, it is important to have a framework in mind of how to deal with a maternal cardiac arrest, and to have practised the response to this situation.
incidental deaths, and are not included in calculation of the MMR.
• Several other risk factors for maternal death are recognised. These include:
• Maternal age 35 and older
• Obesity
• Lower socioeconomic status
• Pre-existing mental health issues, substance use and domestic violence, all of which may be exacerbated by pregnancy and the puerperium
• Medical co-morbidities, particularly asthma, autoimmune diseases, inflammatory and atopic disorders, haematological disorders, essential hypertension, infections and musculoskeletal disorders
One of the important developments in improving identification of a pregnant or postnatal patient at risk of collapse during hospital admission has been the development of maternity-specific Early Warning Charts.
For difficult vaginal delivery,forceps delivery,vacuum application are done to assist the vaginal delivery.Many types of forceps are there divided in 3 categories.
Approach to maternal collapse and cardiac arrest.pptxKTD Priyadarshani
This is a case based discussion on approach to maternal collapse and cardiac arrest. It includes a detailed account on ERC ALS guideline on maternal cardiac arrest and post resuscitation care.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
4. CVS changes in pregnancy
• Cardiac output (CO) ↑ by 20% at 8 weeks of gestation and continues
to rise until 30 to 32 wks, at which point it plateaus at ~ 50% above
baseline until the beginning of labour.
• The rise in CO is due to:
- ↑preload from a rise in blood volume
- ↓ afterload from declining vascular resistance .
- ↑maternal heart rate, by 15 to 20 bpm
• Supine position at term can lower CO by 25 to 30 % cf left lateral
decubitus position, due to compression of IVC by the gravid uterus
5.
6.
7.
8. Pulmonary changes in pregnancy
• Beginning 1st trimester ↑ in tidal vol & respiratory drive (due to the
stimulatory effects of progesterone) cause hyperventilation & a chronic
respiratory alkalosis The compensatory ↓ in the plasma bicarbonate
concentration ↓ its buffering ability.
• Pregnancy-related pulmonary changes include:
- PaO2 may be slightly ↑ at 104 to 108 mmHg as a result of ↑ CO &
minimization of the ventilation-perfusion mismatch in the lung.
- Beginning ~ 20 wks of gestation, upward displacement of the diaphragm
→20% ↓ in functional residual capacity.
- Oxygen consumption ↑ by almost 20%
9.
10. Perimortem Caesarean Section (PCS)
• Before the 20th century CS was only undertaken when the mother
was dead or moribund
• Then in 1980s reports of unexpected maternal recoveries after PCS
• The pregnant uterus & placenta act as a shunt & make maternal
resuscitative efforts less effective
• The removal of the fetus will allow blood to auto-transfuse from the
uterus into the systemic circulation, & may help to both restore
perfusion & enhance the effectiveness of chest compression
• Emptying the uterus may improve maternal resuscitation & perfusion
by eliminating aortocaval compression
11. Purpose of Perimortem Caesarean
section(PCS)
• Primary goal is improvement of maternal, not fetal, resuscitation
• PCS decreases uterine compression on the IVC thus increasing venous
return, resulting in improved maternal cardiac filling pressure.
• PCS also allows for improved respiratory mechanics, as the diaphragm
is lowered after the procedure
12. Special considerations in primary survey
• Airway: There is physiologic narrowing of the upper airways in 3rd trimester
• Use an endotracheal tube 1 size smaller.
• Intubation medications are the same.
• RSI is the preferred method of intubation in 3rd trimester ↑=risk of aspiration.
• Breathing: Pregnant patients are predisposed to rapid ↓ in Pa02 during apnea
• Supplemental O2 all pregnant patient being resuscitated regardless of saturation.
• Circulation: Hypovolemia should be suspected before clinical signs of
hypotension in trauma patients, as the state of hypervolemia & resulting
hemodilution may mask underlying significant blood loss.
• Aggressive volume resuscitation is encouraged regardless of BP.
• Resuscitation of the pregnant patient should include uterine displacement to relieve
compression of the IVC and thus improve cardiac output and restore circulation.
13.
14. When to perform PCS
• Cardiac arrest when gestational age ≥ 24 wks
• When resuscitative efforts deemed appropriate
• After correction of the causes of cardiac arrest – IV access,
catastrophic haemorrhage controlled, airway patency established &
tension pneumothorax & cardiac tamponade excluded
• Wherever possible PCS if no ROSC following 4 mins active CPR
• There is no need to determine if the fetus is alive
15.
16. Maternal & fetal survival
• Uteroplacental flow may require up to 30% of cardiac output
• All evidence shows cardiac compressions more effective after delivery
• Delivery of the near term infant provides 30-80% improvement in
cardiac output
• Best outcomes in terms of infant neurologic status appear to
occur if the infant is delivered within 5 minutes of maternal
cardiac arrest
17.
18.
19.
20. Pregnant trauma patient
Begin Primary survey
Control catastrophic haemorrhage
Airway with C-spine control. Breathing & ventilation
No respiratory effort
Exclude Tension/open pneumothorax
Oxygenate Ventilate
No Palpable Pulse
21. Maternal cardiac arrest
CPR appropriate: Pregnancy Assessment ≥ 20 wks: Chain of survival
Commence cardio-pulmonary resuscitation
Left lateral position/Manual displacement of the uterus
IV or IO access Exclude cardiac tamponade
Prepare for resuscitative hysterotomy/ perimortem CS
No ROSC after 4 minutes of CPR
Perform resuscitative hysterotomy/ peri mortem CS
22. Cord prolapse out of hospital
• Cord prolapse may occur with premature rupture of membranes .
Overt cord prolapse - call for help & assume the knee-chest face-
down position or lie on the floor with pillows to elevate the hips
above the heart till ambulance for hospital transfer. During transfer,
the knee-chest position is potentially unsafe for the mother so a left
lateral position, with pillows under the hip. If possible, the presenting
part should be elevated manually or by bladder distension during the
transfer
• Cord prolapse outside of the hospital setting - poor prognosis. In a
review of large series, cord prolapse occurring outside of the hospital
was associated with perinatal mortality rates of 38 to 44 %
23. Intrauterine resuscitation
• Manually elevate the presenting part (pp) — the most common
intervention for managing cord prolapse - fast, does not require special
equipment, & shown to be effective. While preparations for an emergency
C/S delivery are made, the clinician places his/her hand in the vagina &
gently elevates the fetal head so it is not compressing the cord.
• Place patient in Trendenburg or knee chest position — Attempt to elevate
the fetal head manually to decompress the cord. Placing the patient in
steep Trendelenburg or the knee-chest position may change the
relationship between the fetus & umbilical cord & thereby alleviate cord
compression.
• Retrofill the bladder — with 500 to 700 mls of saline rapidly via a catheter
to distend the bladder→ elevate pp . May be particularly useful as a
temporizing measure when C/S delivery cannot be performed urgently.
• Administer a tocolytic — rapid action to reduce pressure on the cord from
uterine contractions. Terbutaline 0.25mg S/C
24. Overt cord prolapse
• Minimize manipulating an overtly prolapsed cord & avoid exposing
it to the cold environment, which may exacerbate poor perfusion by
inducing spasm of the umbilical artery. Replace an overtly prolapsed
cord in the vagina & keep it moist with wet gauze.
• Perform emergency delivery by the most rapid & safe route, which
is typically C/S –Assisted vaginal delivery may be considered in select
situations when, in the clinician's judgment, the fetus can be
delivered safely & as quickly, or more quickly, than by C/S..
• If the fetal heart rate is present prior to moving to the operating
room, do not pause to recheck it before surgery as should perform
emergency C/S regardless of the findings & attempt neonatal
resuscitation, if required.
25. PPH - Definition
• 10 in 1st 24 after delivery
• Traditional PPH loss of ≥ 500mls of blood
• Major PPH ≥ 1000mls
• Severe PPH ≥ 2000mls
• Incidence of PPH varies widely, depending upon criteria used to
define the disorder. A reasonable estimate is 1 to 5% of deliveries
26. The 4 Ts of PPH
• Tone
• Trauma
• Thrombin
• Tissue
27. Causes PPH
• Uterine atony responsible for 50- 80 % of cases of PPH
• Defect in contractility which inhibits the haemostasis resultant from
occlusion of the blood vessels
• Once abundant bleeding occurs there is loss of coagulation factors
resulting in altered haemostasis
• Placental retention generally 2nd most common 10-30% cases
• Lacerations & trauma 15-20%
• Other causes are responsible for <1% of PPH – coagulopathy (pre-
existing or acquired e.g. Amniotic fluid embolism, HELLP), abruption,
uterine rupture or abnormal placentation
28. Arresting the bleeding
• The commonest cause of PPH is uterine atony
• If uterine atony suspected as cause & other causes excluded
- uterine massage
- bimanual uterine compression
- empty bladder
- oxytocics – syntocinon, ergometrine, carboprost, misoprostol
- surgical intervention – balloon tamponade, haemostatic brace
suture, bilateral ligation of uterine arteries, bilateral ligation of internal
iliacs, selective arterial embolization, hysterectomy
30. The uterotonics
• Which type ?
• What dose ?
• Which route of administration?
• What mode of delivery ?
31. Oxytocics
• Oxytocin is the prophylactic uterotonic of choice after vaginal delivery. Rapid onset
• Requires refrigeration
• Route & dose controversial - probably slow bolus of 5 IU over 1 min
• Others
• Carbetocin - Synthetic analogue of oxytocin with a prolonged duration of action. Dose
also uncertain ? 100 μg
• Ergometrine – somewhat more effective than Syntocinon & longer acting but frequent
adverse events most especially hypertension. Vomiting & nausea is substantially >
Syntocinon. Combination of Syntocinon (5IU) & Ergometrine (0.5mg) better tolerated
• Prostaglandins
Misoprostol (Prostaglandin E1 analogue) – oral, sublingual, rectal or vaginal
Carboprost (15-methyl prostaglandin F2α) – 250mg IMI never IVI. ? given
intramyometrially (but not lic)
Dinoprost (prostaglandin F2α ) – intramyometrial injection only
32. WOMAN trial
• Tranexamic acid reduces death due to bleeding in women with post-
partum haemorrhage with no adverse effects.
• When used as a treatment for PPH, tranexamic acid should be given
as soon as possible after bleeding onset.
33. Management of PPH after vaginal delivery
Initial
management
of PPH
≥ 30
min
Call Obstetric & Anaesthetic team
OBSTETRIC TEAM
• Urinary
catheterisation
• Visual inspection of
lower genital tract
• Uterine Massage
•Repeat uterotonics
•Manual removal of
placenta if not yet
delivered
• Manual exploration
of uterus If placenta
already delivered
ANAESTHETIC TEAM
• Monitor
• Assess & maintain
haemodynamics: plasma
expansion by crystalloids
•Provide anaesthesia for
manual exploration of uterus
•Antibiotic therapy
•Prevention of hypothermia,
oxygen therapy
•Haemocue
•Bloods
COMMUNICATION
Failure of initial
management
34. Failure of initial management
Persistent or
severe PPH
• Carboprost ( beware of
contraindications) 0.25 mg by IMI
repeated at intervals of not < 15 mins to
a max of 8 doses
• Direct intramyometrial injection of
carboprost 0.5 mg with responsibility of
the administering clinician as it is not
recommended for intramyometrial use
•2nd peripheral line
•Bloods – FBP,
Coagulation profile
•Xmatch blood
≥ 30
min
Failure of 2nd line measures
35. Persistent or
severe PPH
Failure of 2nd line measures
Intra- uterine
balloon
tamponnade
Haemodynamically
unstable &/or
Massive haemorrhage
&/or
Embolisation unavailable
Conservative surgery
•Arterial ligation
•Uterine compression
suture
Failure
Haemodynamically stable
&
Embolisation rapidly
available
EMBOLIZATION
Failure
HYSTERECTOMY +/- rFVIIa (after
checking fibrinogen &
platelets
• Fluid resuscitation
(crystalloids/colloids)
•Transfusion of packed
RBC
•Hypothermia prevention
• Laboratory results
• +/- TXA
• +/-Fresh frozen plasma
• +/- Fibrinogen
• +/- Platelets
• +/- Arterial line
• +/- Central venous
• +/- Noradrenaline
Failure
36. 20 PPH
• Secondary PPH is usually associated with endometritis (with or
without retained products of conception).
• Resuscitation & fluid management
• Antibiotic therapy +/_ uterotonics . In situations of excessive or
continued bleeding surgical intervention is usually required